End Cash (Annual)

End Cash: The amount of cash held by the company for the given period.

Nutex Health Inc. (NUTX) had End Cash of $185.57M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$875.26M
Net Income	$70.79M
Cost of Goods Sold	$430.98M
Gross Profit	$444.28M
Operating Expenses	$599.63M
Operating Income	$275.63M
Non-Operating Income/Expense	$-30.84M
Pre-Tax Income	$244.78M
Normalized Pre-Tax Income	$244.78M
Income after Taxes	$180.36M
Income from Continuous Operations	$180.36M
Consolidated Net Income/Loss	$180.36M
Normalized Income after Taxes	$180.36M
EBIT	$275.63M
EBITDA	$296.16M
Weighted-Average Shares Outstanding (Basic)	6.36M
Weighted-Average Shares Outstanding (Diluted)	6.76M
Earnings per Share (EPS) (Basic)	$11.13
Earnings per Share (EPS) (Diluted)	$10.48
Balance Sheet Financials
Current Assets	$538.81M
Property, Plant, and Equipment	$94.58M
Long-Term Assets	$379.71M
Total Assets	$918.52M
Current Liabilities	$157.91M
Long-Term Debt	$298.05M
Long-Term Liabilities	$337.18M
Total Liabilities	$495.09M
Common Equity	$423.44M
Tangible Shareholders Equity	$388.29M
Shareholders Equity	$423.44M
Common Shares Outstanding	7.09M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$248.12M
Cash Flow from Investing Activities	$-5.24M
Cash Flow from Financial Activities	$-97.95M
Beginning Cash	$40.64M
End Cash	$185.57M
Increase/Decrease in Cash	$144.93M
Stock-Based Compensation	$117.00M
Common Stock Dividends Paid	$-74.28M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.41
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.41
Debt to Equity Ratio	0.75
Gross Margin	50.76%
Operating Margin	31.49%
EBIT Margin	31.49%
EBITDA Margin	33.84%
Pre-Tax Profit Margin	27.97%
Profit Margin	8.09%
Free Cash Flow	$245.60M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.95
Inventory Turnover	150.38
Receiveable Turnover	2.69
Days Sales in Receivables	135.71
Return on Equity	42.59%
Return on Tangible Equity	46.45%
Return on Assets	19.64%
Return on Investments	25.00%
Book Value Per Share	$59.75
Free Cash Flow per Share	$36.35
Operating Cash Flow per Share	$36.73

Data from Zacks Investment Research, Inc.